The Observational Medical Outcomes Partnership (OMOP) is a public-private partnership designed to help improve the monitoring of drugs for safety. The partnership is conducting a two-year initiative to research methods that are feasible and useful to analyze existing healthcare databases to identify and evaluate safety and benefit issues of drugs already on the market.
OMOP Specifications for Implementation of Standard Vocabularies in Observational Data Analysis is now available on the OMOP website. It documents how OMOP implemented various vocabularies for observational data analysis as part of the OMOP Common Data Model within the Research Lab (containing Thomson Reuters MarketScan® databases and GE Centricty®) and across the OMOP Distributed Research Partners. For additional content and documentation go to OMOP Standard Terminologies (log-in required).